Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome
First author：Weihua Jia
Corresponding author：Yongjun Wang
essential_information
- Person in charge：Weihua Jia
- Data Sources： TIMS-CHINA
- Number of papers：TIMS-CHINA20150138
- Published time：2015-04-01
2015-04-01
Published articles
Journal：J Clin Neurol
Publication type: Original Contributions
IF(IF): 3.077
PMID: 26424236 Link To Pubmed Full text Download
Background And Purpose
It is unclear whether postthrombolytic antiplatelet (AP) therapy after thrombolytic-related hemorrhage without extensive parenchymal involvement (THEPI) a!ects the clinical outcome. "is study explored whether AP administration in patients with THEPI a!ects short- and long-term outcomes.